Browse Category

Financial Forecasts News 12 December 2025 - 13 December 2025

Wilmar International Limited Stock: Latest News, Forecasts and Analyst Targets (Dec 13, 2025)

Wilmar International Limited Stock: Latest News, Forecasts and Analyst Targets (Dec 13, 2025)

Wilmar International Limited (SGX: F34) is heading into mid-December with investors juggling two very different storylines: improving underlying operating momentum versus a multi-jurisdiction legal overhang that keeps headlines (and sentiment) jumpy. Wilmar shares last closed at S$3.07 on Friday, Dec
Singtel (SGX:Z74) Stock Outlook on 13 Dec 2025: IMDA Fine, Optus Network Risks, Data Centre Strategy, and Analyst Forecasts

Singtel (SGX:Z74) Stock Outlook on 13 Dec 2025: IMDA Fine, Optus Network Risks, Data Centre Strategy, and Analyst Forecasts

Singapore Telecommunications Limited (Singtel) stock is ending 2025 with a rare mix of momentum and messy real‑world headlines: a fresh regulatory penalty in Singapore, ongoing operational scrutiny around Optus in Australia, and a market narrative that increasingly treats Singtel as
Rocket Lab (RKLB) Stock Jumps as Neutron “Hungry Hippo” Clears a Key Milestone — Latest News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Rocket Lab (RKLB) Stock Jumps as Neutron “Hungry Hippo” Clears a Key Milestone — Latest News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

(SEO): Rocket Lab (NASDAQ: RKLB) is rallying after a major Neutron reusability milestone and a busy launch cadence. Here’s the latest news, analyst forecasts, and key risks as of Dec. 12, 2025. Published: December 12, 2025Company: Rocket Lab Corporation (NASDAQ:
Merck (MRK) Stock News Today: Winrevair EU Expansion, Keytruda Patent Headwinds, Analyst Forecasts and What Investors Watch (Dec. 12, 2025)

Merck (MRK) Stock News Today: Winrevair EU Expansion, Keytruda Patent Headwinds, Analyst Forecasts and What Investors Watch (Dec. 12, 2025)

Merck & Co., Inc. (NYSE: MRK) stock traded higher on Friday, December 12, 2025, as investors weighed a new European regulatory tailwind for pulmonary arterial hypertension drug WINREVAIR (sotatercept) against a backdrop of policy-driven vaccine headlines, Keytruda-related legal friction in
Altimmune (ALT) Stock News, Forecasts and Analysis for Dec. 12, 2025: What Investors Are Watching Ahead of Pemvidutide Catalysts

Altimmune (ALT) Stock News, Forecasts and Analysis for Dec. 12, 2025: What Investors Are Watching Ahead of Pemvidutide Catalysts

Altimmune, Inc. (NASDAQ: ALT) is back on many biotech watchlists as investors weigh two competing forces: a near-term clinical and regulatory catalyst calendar for pemvidutide (the company’s lead asset) and a capital-raising backdrop that can quickly change the stock’s risk/reward
1 31 32 33 34 35 67
Go toTop